Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

August 11, 2015

Primary Completion Date

November 8, 2016

Study Completion Date

December 1, 2016

Conditions
Plaque Psoriasis
Interventions
DRUG

IDP-118 Lotion

Lotion

DRUG

IDP-118 Vehicle Lotion

Lotion

Trial Locations (16)

14603

Valeant Site 14, Rochester

23501

Valeant Site 11, Norfolk

33601

Valeant Site 2, Tampa

36601

Valeant Site 3, Mobile

37115

Valeant Site 6, Nashville

40202

Valeant Site 8, Louisville

46601

Valeant Site 7, South Bend

48036

Valeant Site 13, Clinton Township

73344

Valeant Site 5, Austin

77001

Valeant Site 4, Houston

80123

Valeant Site 16, Denver

90210

Valeant Site 9, Beverly Hills

91316

Valeant Site 12, Encino

92093

Valeant Site 10, San Diego

95403

Valeant Site 1, Santa Rosa

99201

Valeant Site 15, Spokane

Sponsors
All Listed Sponsors
collaborator

Dow Pharmaceutical Sciences

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY